MONROVIA, Calif., Aug. 25 /PRNewswire-FirstCall/ -- STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Roth Capital Partners, a full service investment bank, has invited STAAR Surgical to present at its “Best Ideas” Conference to be held August 28 - 31 at the Palmilla Hotel in Cabo San Lucas, Mexico. At the conference, investment analysts from approximately 20 investment firms will present their current best ideas side- by-side with company management. Barry G. Caldwell, STAAR Surgical’s President and Chief Executive Officer, will discuss the company’s business strategy and historical financial performance at 2:30 p.m. Mountain Time on Thursday, August 28th.
The Roth “Best Ideas” Conference will feature presentations in a roundtable-style format. Presenting companies have been handpicked by the best and brightest minds from leading institutional investors to showcase their best stock picks. Additional topics during the conference include: the U.S. and global economics, energy and key developments in emerging economics.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR’s products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. Collamer(R) is the brand name for STAAR’s proprietary collagen copolymer lens material. More information is available at www.staar.com.
CONTACT: Investors, Dahlia Bailey, +1-415-896-5862, or Media, Chris Gale,
+1-646-201-5431, both of EVC Group, for STAAR Surgical Inc.
Web site: http://www.staar.com/
